Moza makes some of the best (and best value) sim racing gear available, from affordable entry-level bundles to increasingly exotic wheel bases, wheel rims and pedals. We're looking at the latter end ...

The washed-up platforming mascot is back. Again. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Add us as a preferred source on Google Polite ...

On the first day of the Hungry Ghost Month last Saturday (Aug 23), a group of devotees in Sembawang struck it big after betting on a 'lucky' 4D number posted at the prayer altar. The 'lucky' number ...

Publisher Atari and developer Fabraz have announced Bubsy 4D for PlayStation 5, Xbox Series, Switch 2, PlayStation 4, Xbox One, Switch, and PC (Steam, Epic Games Store, GOG). A release date was not ...

Bubsy the Bobcat, star of the eponymous, oft-derided Bubsy series of hit-or-miss platforming games, is back in a new adventure called Bubsy 4D. Publisher Atari and developer Fabraz, known for the ...

Atari has announced a brand-new Bubsy game – no, really! In collaboration with developer Fabraz, known for the rather excellent Demon Turf, Bubsy 4D will launch on the Switch and Switch 2. And it ...

The Gauteng Department of Roads and Transport has issued a public notice announcing scheduled lane closures along the R25 Modderfontein Road to accommodate ongoing construction work. The affected ...

How Far Will Experimenting on the Unborn Go? The War on Christmas (Eating, Drinking, Fun) Audio By Carbonatix Donald Trump has said some pretty grotesque things about Ukraine over the last 48 hours, ...

In April 1982, Prof. Dan Shechtman of the Technion–Israel Institute of Technology made the discovery that would later earn him the 2011 Nobel Prize in Chemistry: the quasiperiodic crystal. According ...

Gutenberg’s printing press revolutionized the way the written word was replicated, bringing two-dimensional printing into the world and so vastly increasing accessibility of information. From that ...

Please provide your email address to receive an email when new articles are posted on . Patients who received 4D-150 3E10 vg/eye experienced an 8.4 letter increase in BCVA. 4DMT is progressing to a ...

4D Molecular Therapeutics is axing two clinical programs and cutting off funds for three other assets, with resources to be pivoted toward launching late-stage studies for the biotech's eye disease ...